Nexalin Therapy for the Treatment of Depressive Symptoms
NCT00774813
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Depression
Interventions
DEVICE:
Nexalin 1.3mA Device
DEVICE:
Nexalin 15mA device
DRUG:
placebo device and Citalopram
Sponsor
Kalaco Scientific, Inc.